Literature DB >> 23689062

L2, the minor capsid protein of papillomavirus.

Joshua W Wang1, Richard B S Roden.   

Abstract

The capsid protein L2 plays major roles in both papillomavirus assembly and the infectious process. While L1 forms the majority of the capsid and can self-assemble into empty virus-like particles (VLPs), L2 is a minor capsid component and lacks the capacity to form VLPs. However, L2 co-assembles with L1 into VLPs, enhancing their assembly. L2 also facilitates encapsidation of the ∼8 kbp circular and nucleosome-bound viral genome during assembly of the non-enveloped T=7d virions in the nucleus of terminally differentiated epithelial cells, although, like L1, L2 is not detectably expressed in infected basal cells. With respect to infection, L2 is not required for particles to bind to and enter cells. However L2 must be cleaved by furin for endosome escape. L2 then travels with the viral genome to the nucleus, wherein it accumulates at ND-10 domains. Here, we provide an overview of the biology of L2.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Daxx; E2; Encapsidation; Furin; HPV; Infection; L1; L2; Minor capsid protein; ND-10; Papillomavirus; SP100

Mesh:

Substances:

Year:  2013        PMID: 23689062      PMCID: PMC3770800          DOI: 10.1016/j.virol.2013.04.017

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  121 in total

1.  Identification and characterization of the BPV-2 L2 protein.

Authors:  R A Rippe; W J Meinke
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

Review 2.  The role of furin in papillomavirus infection.

Authors:  Patricia M Day; John T Schiller
Journal:  Future Microbiol       Date:  2009-12       Impact factor: 3.165

3.  DNA-binding activity of papillomavirus proteins.

Authors:  R G Mallon; D Wojciechowicz; V Defendi
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

4.  Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a.

Authors:  J Doorbar; P H Gallimore
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

5.  Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines.

Authors:  C C Baker; W C Phelps; V Lindgren; M J Braun; M A Gonda; P M Howley
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

6.  Identification of L2 open reading frame gene products of bovine papillomavirus type 1 using monoclonal antibodies.

Authors:  X W Jin; L M Cowsert; W P Pilacinski; A B Jenson
Journal:  J Gen Virol       Date:  1989-05       Impact factor: 3.891

7.  Expression of the full-length products of the human papillomavirus type 6b (HPV-6b) and HPV-11 L2 open reading frames by recombinant baculovirus, and antigenic comparisons with HPV-11 whole virus particles.

Authors:  R C Rose; W Bonnez; D G Strike; R C Reichman
Journal:  J Gen Virol       Date:  1990-11       Impact factor: 3.891

8.  The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes.

Authors:  N D Christensen; J W Kreider; N C Kan; S L DiAngelo
Journal:  Virology       Date:  1991-04       Impact factor: 3.616

Review 9.  Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus.

Authors:  Martin Sapp; Malgorzata Bienkowska-Haba
Journal:  FEBS J       Date:  2009-12       Impact factor: 5.542

10.  Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus.

Authors:  Y L Lin; L A Borenstein; R Selvakumar; R Ahmed; F O Wettstein
Journal:  Virology       Date:  1992-04       Impact factor: 3.616

View more
  83 in total

1.  Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.

Authors:  Max A Cheng; Emily Farmer; Claire Huang; John Lin; Chien-Fu Hung; T-C Wu
Journal:  Hum Gene Ther       Date:  2018-03-16       Impact factor: 5.695

2.  Naturally Occurring Capsid Protein Variants of Human Papillomavirus Genotype 31 Represent a Single L1 Serotype.

Authors:  Sara L Bissett; Anna Godi; Maxime J J Fleury; Antoine Touze; Clementina Cocuzza; Simon Beddows
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

Review 3.  Virus Isoelectric Point Estimation: Theories and Methods.

Authors:  Joe Heffron; Brooke K Mayer
Journal:  Appl Environ Microbiol       Date:  2021-01-15       Impact factor: 4.792

4.  Improved Virus Isoelectric Point Estimation by Exclusion of Known and Predicted Genome-Binding Regions.

Authors:  Joe Heffron; Brooke K Mayer
Journal:  Appl Environ Microbiol       Date:  2020-11-10       Impact factor: 4.792

5.  Superinfection Exclusion between Two High-Risk Human Papillomavirus Types during a Coinfection.

Authors:  Jennifer Biryukov; Craig Meyers
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

6.  Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes.

Authors:  Subhashini Jagu; Balusubramanyam Karanam; Joshua W Wang; Hatem Zayed; Margit Weghofer; Sarah A Brendle; Karla K Balogh; Kerstin Pino Tossi; Richard B S Roden; Neil D Christensen
Journal:  Vaccine       Date:  2015-09-15       Impact factor: 3.641

Review 7.  Concepts of papillomavirus entry into host cells.

Authors:  Patricia M Day; Mario Schelhaas
Journal:  Curr Opin Virol       Date:  2013-12-14       Impact factor: 7.090

Review 8.  Immunoprevention of human papillomavirus-associated malignancies.

Authors:  Joshua W Wang; Chein-Fu Hung; Warner K Huh; Cornelia L Trimble; Richard B S Roden
Journal:  Cancer Prev Res (Phila)       Date:  2014-12-08

9.  The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis.

Authors:  Elena Wüstenhagen; Laura Hampe; Fatima Boukhallouk; Marc A Schneider; Gilles A Spoden; Inka Negwer; Kaloian Koynov; W Martin Kast; Luise Florin
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

10.  Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins.

Authors:  Matthew P Bronnimann; Christine M Calton; Samantha F Chiquette; Shuaizhi Li; Mingfeng Lu; Janice A Chapman; Kristin N Bratton; Angela M Schlegel; Samuel K Campos
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.